Latest market price
43.91
+0.20+0.46%
OverviewShort InterestFilings
XTENBondBloxx Bloomberg Ten Year Target Duration US Treasury ETF·AMEX
43.91+0.46%
TA
Loading chart...
Screen all →
VXUS-1.53%$82.37VUG-3.00%$85.06VTV-0.38%$228.02VO-0.95%$81.46VGT-4.32%$116.96VB-1.58%$290.05VWO-1.93%$55.51VIG-0.56%$247.76
Fund Snapshot
Category—Asset TypeFixed IncomeTagstreasury-bondsReturn% 1Y-3.75%Total Holdings0Perf Week0.69%
SponsorBondBloxxETF TypeTags—Return% 3Y4.18%AUM$1.39BPerf Month3.76%
Fund FamilyBond TypeTags—Return% 5Y—NAV/shPerf Quarter-0.70%
Index—Average MaturityTags—Return% 10Y52W High47.49 -7.54%Perf Half Y-3.43%
Index WeightingCommodity TypeTags—Return% SI52W Low41.84 4.95%Perf YTD-5.00%
Active/PassiveQuant TypeTags—Flows% 1M0.00%Volatility0.46% 0.58%Perf Year-6.69%
Dividend TTM1.96 (4.46%)ESG TypeTags—Flows% 3M0.00%ATR (14)0.30Perf 3Y2.35%
Dividend Ex-DateOct 01, 2026Dividend TypeSector/ThemeFlows% YTD5.48%RSI (14)64.49Perf 5Y—
Dividend Gr. 3/5Y—Structure TypeRegionFlows% 1YBeta0.15Perf 10Y—
Expense0.07%Growth/ValueSMA202.12%Flows% 3YRel Volume0.83Prev Close43.71
Inverse/LeveragedMarket CapSMA501.26%Flows% 5YAvg Volume326.42KPrice43.91
IPO DateSep 13, 2022Option/ShortYes / YesSMA200-2.47%52W Range %37%Volume270,164Change0.46%
Holdings Breakdown
View Holdings as
Stocks
0.0%Financial Services
Bonds, Cash & Other
100.0%Cash & Others
Assets Under Management
00.30B0.60B0.90B1.20BAprJunAugOct'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Oct-21-26
Oct-21-2604:17AM
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF $XTEN Stake Reduced by DUTCH ASSET Corpdefenseworld.net
Oct-16-26
Oct-16-2602:43AM
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF (NYSEARCA:XTEN) Stock Short Interest Report for Septemberdefenseworld.net
Oct-15-26
Oct-15-2603:47AM
15,395 Shares in BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF $XTEN Bought by Sax Wealth Advisors LLCdefenseworld.net
Oct-14-26
Oct-14-2608:30AM
Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumorsbusinesswire.com
Oct-08-26
Oct-08-2608:30AM
Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancerbusinesswire.com
Jul-24-26
Jul-24-2603:06PM
Why Investors Are Eyeing Short & Long U.S. Treasury ETFsetftrends.com
Fund

Under typical conditions, this fund commits at least 80% of its total investment capital (including any borrowed funds) to a portfolio predominantly made up of U.S. Treasury debt instruments. These holdings are strategically assembled to collectively achieve a mean duration of around ten years, acquired either through direct ownership or indirectly via financial contracts like derivatives. The fund's underlying index consists of particular U.S. Treasury notes and bonds that are constituents of the broader Bloomberg US Treasury Index. It operates as a non-diversified investment vehicle.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR